Positron Corp. (OTCMKTS:POSC) Shares Shorted: Short Interest Down 97.1% in October

Positron Corp. (OTCMKTS:POSC) was the target of a large decline in short interest during the month of October. As of October 15th, there was short interest totaling 262 shares, a decline of 97.1% from the September 30th total of 9,086 shares. Based on an average daily trading volume, of 32,692 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are short sold.

Positron Stock Performance

Shares of POSC traded up $0.03 during mid-day trading on Monday, hitting $1.70. 215 shares of the company traded hands, compared to its average volume of 16,183. The stock has a market cap of $56.27 million, a price-to-earnings ratio of -5.31 and a beta of 0.53. The stock has a 50-day moving average price of $1.74 and a two-hundred day moving average price of $1.82. Positron has a 1 year low of $1.27 and a 1 year high of $2.74.

Positron (OTCMKTS:POSC) last issued its earnings results on Friday, August 14th. The company reported ($0.03) earnings per share (EPS) for the quarter. The company had revenue of $0.11 million during the quarter. Positron had a negative return on equity of 2,415.88% and a negative net margin of 2,279.55%.

Positron Company Profile

Positron Corporation (OTCMKTS: POSC) is a medical technology company focused on positron emission tomography (PET), a nuclear-imaging technique used to support the diagnosis and management of disease. Its activities include the development, manufacture and distribution of PET imaging systems and related products for healthcare providers.

The company has emphasized cardiac PET imaging, an application that can help physicians evaluate heart function and blood flow. Positron’s product offerings have included dedicated PET equipment, such as the Attrius PET system, along with related imaging and radiopharmaceutical solutions.